Apriso Capsule, Extended Release
Product Images NDC 65649-103

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Apriso (NDC 65649-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salix Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagram of mesalamine, the active ingredient in APRISO 375 mg extended-release capsules. The structure shows a benzene ring with amino, hydroxyl, and carboxyl functional groups.*

FDA Label Image

0.375gaprisolabel (Image 02)

Label for APRISO (mesalamine) extended-release capsules, 0.375 g strength. The label indicates a 120 capsule count and includes product and dosage details, storage instructions, and distributor information for Salix Pharmaceuticals. The label features a barcode and the NDC 65649-103-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.